January 26, 2015 2:23 PM ET


Company Overview of Lux Biosciences, Inc.

Company Overview

Lux Biosciences, Inc. operates a biotechnology company which develops and commercializes medications for ophthalmic diseases in the United States and internationally. Its products comprise LUVENIQ, an oral form of calcineurin inhibitor voclosporin, which is used for the treatment of non-infectious uveitis; LX214, a topical formulation that contains mixed nanomicelles of voclosporin for ophthalmic use; LX212, a bioerodible polymer implant containing voclosporin; and LX213, a bioerodible/isotechnika implant. The company was incorporated in 2005 and is based in Jersey City, New Jersey.

3 Second Street

Harborside Financial Center Plaza 10

14th Floor

Jersey City, NJ 07302

United States

Founded in 2005





Key Executives for Lux Biosciences, Inc.

Co-Founder and Chief Operating Officer
President of Europe Region and Managing Director of Lux Biosciences GmbH
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Micell Technologies, Inc. United States
Irvine Scientific Sales Company, Inc. United States
Cylene Pharmaceuticals, Inc. United States
Liventa Bioscience United States
Elan Pharmaceutical Investments Ltd. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lux Biosciences, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.